Press briefing on the conclusion of the assessment of the Pharmacovigilance Risk Assessment Committee (PRAC) of Vaxzevria (previously COVID-19 Vaccine AstraZeneca) and thromboembolic events

• Date:
  Wednesday, 07 April 2021
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

EMA is holding a virtual press briefing on the conclusion of the evaluation of a safety signal with Vaxzevria (previously COVID-19 Vaccine AstraZeneca) relating to cases of thromboembolic events by EMA’s safety committee (PRAC) on 7 April 2021.

Speakers:

• Emer Cooke (Executive Director)
• Sabine Straus (Chair of PRAC) 
• Peter Arlett (Head of Data Analytics and Methods Task Force) 

The press briefing will be moderated by Ms Marie-Agnes Heine (Head of Communication). The press briefing will be held in English.

Live broadcast - 16:00 - 16:45 CEST

To view the broadcast please ensure you meet the YouTube requirements. To view the video in the highest quality, click on the 'Settings' symbol in the right-hand corner of the video player and select '720p' or a higher resolution.